SCHEMBL1901329

SCHEMBL1901329

C=CCC(CC)CCCCCCCCCC

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
TSHR P16473 7/20 0.44
ALDH1A1 P00352 4/20 0.41
TDP1 Q9NUW8 2/20 0.41
CYP3A4 P08684 2/20 0.40
FAAH O00519 1/20 0.36
DNM1 Q05193 2/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
ADH1B P00325 1/20 0.35
ADH1C P00326 1/20 0.35
ADH1A P07327 1/20 0.35
ADH4 P08319 1/20 0.35
ADH7 P40394 1/20 0.35
ATM Q13315 1/20 0.35
THRB P10828 1/20 0.35
OPRM1 P35372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10875533 1.00 LMNA (0.46) LMNATSHRALDH1A1TDP1CYP3A4
SCHEMBL1902832 1.00 LMNA (0.46) LMNATSHRALDH1A1TDP1CYP3A4
SCHEMBL1905280 1.00 LMNA (0.46) LMNATSHRALDH1A1TDP1CYP3A4
SCHEMBL25171268 1.00 LMNA (0.46) LMNATSHRALDH1A1TDP1CYP3A4
SCHEMBL10703575 1.00 LMNA (0.46) LMNATSHRALDH1A1TDP1CYP3A4
SCHEMBL25172392 1.00 LMNA (0.46) LMNATSHRALDH1A1TDP1CYP3A4
SCHEMBL25185251 0.98 ALDH1A1 (0.43) LMNATSHRALDH1A1TDP1CYP3A4
SCHEMBL25181795 0.91 LMNA (0.50) LMNATSHRALDH1A1FAAHDNM1
SCHEMBL15687620 0.91 LMNA (0.50) LMNATSHRALDH1A1FAAHDNM1
SCHEMBL9445614 0.91 LMNA (0.50) LMNATSHRALDH1A1FAAHDNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118201905-A Cationic lipid 武田药品工业株式会社 2024-06-14 CN disclosed
WO-2023085299-A1 CATIONIC LIPID 武田薬品工業株式会社 2023-05-19 WO disclosed
US-9303111-B2 Acrylate-olefin copolymers, methods for producing same and compositions utilizing same LUBRIZOL ADVANCED MATERIALS, INC. (US) 2016-04-05 US disclosed
US-20140275460-A1 Acrylate-Olefin Copolymers, Methods For Producing Same And Compositions Utilizing Same LUBRIZOL ADVANCED MATERIALS, INC. (US) 2014-09-18 US disclosed
EP-2773679-A1 ACRYLATE-OLEFIN COPOLYMERS, METHODS FOR PRODUCING SAME AND COMPOSITIONS UTILIZING SAME Lubrizol Advanced Materials, Inc. (US) 2014-09-10 EP disclosed
WO-2013067109-A1 ACRYLATE-OLEFIN COPOLYMERS, METHODS FOR PRODUCING SAME AND COMPOSITIONS UTILIZING SAME LUBRIZOL ADVANCED MATERIALS, INC. (US) 2013-05-10 WO disclosed
EP-2496628-A1 METHOD FOR PRODUCING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2012-09-12 EP disclosed
US-20120208959-A1 METHOD FOR PRODUCING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2012-08-16 US disclosed
WO-2012076426-A1 METHOD FOR PRODUCING AN AQUEOUS POLYMER PRODUCT DISPERSION BASF SE (DE) 2012-06-14 WO disclosed
US-20120149840-A1 PROCESS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION Univ. of Southern Mississippi Res. Foundation (US) 2012-06-14 US disclosed
US-20100069597-A1 FINE-PARTICLED POLYMER DISPERSIONS CONTAINING STARCH BASF SE (DE) 2010-03-18 US disclosed
US-20100022708-A1 DISPERSING ASSISTANT FOR EMULSION AND SUSPENSION POLYMERIZATION BASF SE (DE) 2010-01-28 US disclosed
EP-2121780-A2 FINE-PARTICLED POLYMER DISPERSIONS CONTAINING STARCH BASF SE (DE) 2009-11-25 EP disclosed
WO-2009135812-A1 METHOD FOR PREPARING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2009-11-12 WO disclosed
US-20090275681-A1 PROCESS FOR PREPARING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2009-11-05 US disclosed
EP-2066701-A1 PROCESS FOR PREPARING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2009-06-10 EP disclosed
WO-2009047232-A1 AQUEOUS BINDER FOR FIBROUS OR GRANULAR SUBSTRATES BASF SE (DE) 2009-04-16 WO disclosed
WO-2008055858-A2 FINE-PARTICLED POLYMER DISPERSIONS CONTAINING STARCH BASF SE (DE) 2008-05-15 WO disclosed
WO-2008031790-A1 PROCESS FOR PREPARING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2008-03-20 WO disclosed
US-3993071-A Bioerodible ocular device ALZA CORPORATION (US) 1976-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149840-A1 PROCESS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION PUF60, PARG, ACMSD LMNA 2901/4885TSHR 4835/4885ALDH1A1 3496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.